25-NSE ·Filed Apr 23, 2026

DAWN

Day One Biopharmaceuticals, Inc.
NEUTRAL
Impact 9/10
Horizonimmediate Processed5mo ago SEC0001354457-26-000366
Notable filing: 25-NSE
Actionable Insight • Neutral

Shares will cease trading and be removed from Nasdaq; investors should expect final settlement from the acquisition. No further public filings or trading activity will occur.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+1d ⚠ clustered
DAWN ▲ 0.00% at T+1d
NEUTRAL call ✗ call lost 0.00% · α vs SPY -0.78% · entry $21.53 → $21.53
Next anchor: T+5d due 5mo ago
Entry anchored
Apr 22, 04:00 PM ET
via exchange tick
T+1d
0.00%
call 0.00% · α -0.78%
$21.53
settled 5mo ago
T+5d
—
call — · α —
—
due 5mo ago
T+20d
—
call — · α —
—
due 4mo ago
T+60d
—
call — · α —
—
due 2mo ago

Price Chart

Loading chart...

Executive Summary

Nasdaq has filed Form 25 to delist Day One Biopharmaceuticals (DAWN) common stock, effective immediately, following the company's acquisition by Servier Pharmaceuticals. This is a procedural step confirming the completion of the take-private transaction.

Key Facts

  • Form 25-NSE filed by Nasdaq to delist DAWN common stock
  • Effective date of delisting is 2026-04-23
  • Follows the previously announced acquisition of Day One by Servier Pharmaceuticals
  • Merger closed after Servier secured 85.34% of shares via tender offer
  • DAWN is no longer a publicly traded company

Financial Impact

Entire company acquired for $2.5 billion in all-cash transaction

marketCapsharesOutstandingliquidity

Risk Factors

  • None for public shareholders — transaction is complete and fully settled
  • Loss of liquidity for former shareholders who did not tender

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (13 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0001354457-26-000366
Document: 0001354457-26-000366-index-headers.html0001354457-26-000366
Document: 0001354457-26-000366-index.html0001354457-26-000366
Document: 0001354457-26-000366.txt0001354457-26-000366
6 reports for DAWN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for DAWN — sortable, filterable
TypeNow
May 4, 2026
21w ago
15-12G
NEUTRAL ★ 5/10
—awaiting T+1——
Apr 23, 2026
23w ago
25-NSE
NEUTRAL ★ 9/10
$21.53 $21.53· 0.00%▼ −0.78%—
Apr 23, 2026
23w ago
8-K
NEUTRAL ★ 9/10
$21.53 $21.53· 0.00%▼ −0.78%—
Apr 17, 2026
23w ago
10-K/A
NEUTRAL ★ 4/10
$21.48 $21.49▲ +0.05%▲ +0.70%—
Mar 6, 2026
30w ago
Press Release
BULLISH ★ 9/10
$21.20 $21.33▲ +0.61%▼ −0.23%—
Feb 24, 2026
31w ago
8-K
BULLISH ★ 8/10
$10.92 $10.65▼ −2.43%▼ −1.88%—
Showing 6 of 6

US Market Status

Market Open — Closes in 2h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access